10 20 30 40 50 60 70 80 1PIC - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER COMPLEX (PHOSPHOTRANSFERASE/RECEPTOR) 23-JUN-97 1PIC
TITLE PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C- TITLE 2 TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE TITLE 3 FROM THE PDGF RECEPTOR, NMR, MINIMIZED MEAN STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 3-KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL SH2 DOMAIN, RESIDUES 617 - 724 OF P85- COMPND 5 ALPHA REGULATORY SUBUNIT; COMPND 6 EC: 2.7.1.137; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: CONTAINS AN N-TERMINAL EXTENSION (GSPI) COMPND 9 DERIVED FROM THE RECOMBINANT EXPRESSION VECTOR; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: BETA-PLATELET-DERIVED GROWTH FACTOR RECEPTOR; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: ACETYL-PTYR-VAL-PRO-MET-LEU, RESIDUES 751 - 755; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: TYROSINE-PHOSPHORYLATED PEPTIDE COMPND 16 INCORPORATES AN N-TERMINAL ACETYL GROUP
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: W3110 (CGSC 6564); SOURCE 8 MOL_ID: 2
KEYWDS PHOSPHOTRANSFERASE, SH2 DOMAIN, SIGNAL TRANSDUCTION, KEYWDS 2 PHOSPHOINOSITIDE 3-KINASE, COMPLEX KEYWDS 3 (PHOSPHOTRANSFERASE/RECEPTOR)
EXPDTA SOLUTION NMR
AUTHOR A.L.BREEZE,B.V.KARA,D.G.BARRATT,M.ANDERSON,J.C.SMITH, AUTHOR 2 R.W.LUKE,J.R.BEST,S.A.CARTLIDGE
REVDAT 2 24-FEB-09 1PIC 1 VERSN REVDAT 1 17-SEP-97 1PIC 0
JRNL AUTH A.L.BREEZE,B.V.KARA,D.G.BARRATT,M.ANDERSON, JRNL AUTH 2 J.C.SMITH,R.W.LUKE,J.R.BEST,S.A.CARTLIDGE JRNL TITL STRUCTURE OF A SPECIFIC PEPTIDE COMPLEX OF THE JRNL TITL 2 CARBOXY-TERMINAL SH2 DOMAIN FROM THE P85 ALPHA JRNL TITL 3 SUBUNIT OF PHOSPHATIDYLINOSITOL 3-KINASE. JRNL REF EMBO J. V. 15 3579 1996 JRNL REFN ISSN 0261-4189 JRNL PMID 8670861
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION ABOVE.
REMARK 4 REMARK 4 1PIC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ, 750 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED BY TRIPLE-RESONANCE NMR ON REMARK 210 13C,15N-LABELLED SH2 DOMAIN COMBINED WITH ISOTOPE-FILTERED 1H- REMARK 210 NMR FOR THE UNLABELLED BOUND PEPTIDE.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 17 52.08 87.68 REMARK 500 ASN A 18 57.37 -155.83 REMARK 500 ARG A 19 -71.30 -78.33 REMARK 500 ARG A 27 89.09 -57.75 REMARK 500 LYS A 29 -176.14 -57.11 REMARK 500 GLU A 38 -161.17 -125.04 REMARK 500 SER A 39 -157.48 -177.57 REMARK 500 LYS A 41 -178.33 -52.88 REMARK 500 CYS A 44 -166.76 -75.45 REMARK 500 LYS A 62 -55.41 -132.90 REMARK 500 THR A 65 -29.64 -172.00 REMARK 500 ALA A 70 -26.46 166.54 REMARK 500 ASN A 74 -159.30 49.03 REMARK 500 LEU A 75 -109.86 -129.42 REMARK 500 TYR A 76 122.41 73.32 REMARK 500 SER A 77 41.54 -101.40 REMARK 500 LEU A 98 -77.68 -107.25 REMARK 500 ALA A 108 -166.92 43.20 REMARK 500 GLN A 109 45.25 174.02 REMARK 500 ARG A 111 -94.39 -111.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 19 0.24 SIDE_CHAIN REMARK 500 ARG A 27 0.28 SIDE_CHAIN REMARK 500 ARG A 30 0.28 SIDE_CHAIN REMARK 500 ARG A 37 0.24 SIDE_CHAIN REMARK 500 ARG A 112 0.28 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE B 200
DBREF 1PIC A 5 112 UNP P27986 P85A_HUMAN 617 724 DBREF 1PIC B 200 205 PDB 1PIC 1PIC 200 205
SEQRES 1 A 112 GLY SER PRO ILE PRO HIS HIS ASP GLU LYS THR TRP ASN SEQRES 2 A 112 VAL GLY SER SER ASN ARG ASN LYS ALA GLU ASN LEU LEU SEQRES 3 A 112 ARG GLY LYS ARG ASP GLY THR PHE LEU VAL ARG GLU SER SEQRES 4 A 112 SER LYS GLN GLY CYS TYR ALA CYS SER VAL VAL VAL ASP SEQRES 5 A 112 GLY GLU VAL LYS HIS CYS VAL ILE ASN LYS THR ALA THR SEQRES 6 A 112 GLY TYR GLY PHE ALA GLU PRO TYR ASN LEU TYR SER SER SEQRES 7 A 112 LEU LYS GLU LEU VAL LEU HIS TYR GLN HIS THR SER LEU SEQRES 8 A 112 VAL GLN HIS ASN ASP SER LEU ASN VAL THR LEU ALA TYR SEQRES 9 A 112 PRO VAL TYR ALA GLN GLN ARG ARG SEQRES 1 B 6 ACE PTR VAL PRO MET LEU
MODRES 1PIC PTR B 201 TYR O-PHOSPHOTYROSINE
HET ACE B 200 6 HET PTR B 201 24
HETNAM ACE ACETYL GROUP HETNAM PTR O-PHOSPHOTYROSINE
HETSYN PTR PHOSPHONOTYROSINE
FORMUL 2 ACE C2 H4 O FORMUL 2 PTR C9 H12 N O6 P
HELIX 1 1 ARG A 19 LEU A 26 1 8 HELIX 2 2 LEU A 79 HIS A 88 1 10
SHEET 1 A 3 PHE A 34 ARG A 37 0 SHEET 2 A 3 ALA A 46 VAL A 51 -1 N SER A 48 O LEU A 35 SHEET 3 A 3 GLU A 54 VAL A 59 -1 N CYS A 58 O CYS A 47
LINK C ACE B 200 N PTR B 201 1555 1555 1.31 LINK C PTR B 201 N VAL B 202 1555 1555 1.30
SITE 1 AC1 2 HIS A 57 VAL B 202
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000